Literature DB >> 17096709

Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors.

Esko J Wiltshire1, Kirsty Newton, Lindsay McTavish.   

Abstract

AIM: To determine prevalence of hypoglycaemia, and contributing factors, in children with type 1 diabetes, using the Medtronic MiniMed continuous glucose monitoring system (CGMS).
METHODS: Fifty-one children and adolescents with diabetes were studied with the CGMS. The studies were analysed for frequency and duration of hypoglycaemia (below 3.5 and 2.5 mmol/L). Contributing clinical factors were determined. Occurrence of nocturnal hypoglycaemia was related to bedtime and fasting home glucose recording.
RESULTS: Hypoglycaemia was common, with 1 (0-4.2) (median (range)) episode per patient per 24 hours, and 0.33 (0-2) episodes per patient per night. Nocturnal episodes were longer than daytime episodes [97.5 (5-720) versus 35 (5-295) minutes for episodes below 3.5 mmol/L, P < 0.001; and 75 (10-640) versus 25 (5-200) minutes for episodes below 2.5 mmol/L, P < 0.001], and less likely to be recognised by the subject (P < 0.001 for episodes below both 3.5 and 2.5 mmol/L). Nocturnal hypoglycaemia was more common with a bedtime glucose recording <6 mmol/L, but also occurred frequently in subjects with glucose recordings >10 mmol/L. No bedtime glucose value reduced the risk of nocturnal hypoglycaemia to <10%.
CONCLUSION: Hypoglycaemia, assessed using the CGMS, is common in children with type 1 diabetes and can be prolonged (although is predominantly mild). Bedtime home glucose recordings are poorly predictive of hypoglycaemia during the following night. Continuous glucose monitoring has proven very useful in management of individual patients, particularly adolescents experiencing difficulties with adherence to diabetes management.

Entities:  

Mesh:

Year:  2006        PMID: 17096709     DOI: 10.1111/j.1440-1754.2006.00973.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  11 in total

1.  Gcg-XTEN: an improved glucagon capable of preventing hypoglycemia without increasing baseline blood glucose.

Authors:  Nathan C Geething; Wayne To; Benjamin J Spink; Michael D Scholle; Chia-wei Wang; Yong Yin; Yi Yao; Volker Schellenberger; Jeffrey L Cleland; Willem P C Stemmer; Joshua Silverman
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

2.  Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

3.  Hypoglycemia-associated autonomic failure in healthy humans: comparison of two vs three periods of hypoglycemia on hypoglycemia-induced counterregulatory and symptom response 5 days later.

Authors:  A Moheet; A Kumar; L E Eberly; J Kim; R Roberts; E R Seaquist
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

Review 4.  Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.

Authors:  Candace M Reno; Marina Litvin; Amy L Clark; Simon J Fisher
Journal:  Endocrinol Metab Clin North Am       Date:  2012-12-12       Impact factor: 4.741

5.  The role of continuous glucose monitoring in the care of children with type 1 diabetes.

Authors:  Noelle S Larson; Jordan E Pinsker
Journal:  Int J Pediatr Endocrinol       Date:  2013-03-26

6.  Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?

Authors:  Sumie Mitsuishi; Rimei Nishimura; Kiyotaka Ando; Daisuke Tsujino; Kazunori Utsunomiya
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

7.  Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia.

Authors:  Betty Korljan Jelaska; Sanja Baršić Ostojić; Nina Berović; Višnja Kokić
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2013-12-01

8.  Continuous determination of blood glucose in children admitted with malaria in a rural hospital in Mozambique.

Authors:  Lola Madrid; Antonio Sitoe; Rosauro Varo; Tacilta Nhampossa; Miguel Lanaspa; Abel Nhama; Sozinho Acácio; Isolina Riaño; Aina Casellas; Quique Bassat
Journal:  Malar J       Date:  2017-05-02       Impact factor: 2.979

9.  Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.

Authors:  Hiroshi Takahashi; Rimei Nishimura; Yoshiko Onda; Kiyotaka Ando; Daisuke Tsujino; Kazunori Utsunomiya
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

10.  Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.

Authors:  Julia Fuchs; Janet M Allen; Charlotte K Boughton; Malgorzata E Wilinska; Ajay Thankamony; Carine de Beaufort; Fiona Campbell; James Yong; Elke Froehlich-Reiterer; Julia K Mader; Sabine E Hofer; Thomas M Kapellen; Birgit Rami-Merhar; Martin Tauschmann; Korey Hood; Barbara Kimbell; Julia Lawton; Stephane Roze; Judy Sibayan; Nathan Cohen; Roman Hovorka
Journal:  BMJ Open       Date:  2021-02-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.